Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 2 results for "praful bohra"

Hold Cipla; on track to meet 20%+ EBITDA margins in'16: Religare

Praful Bohra of Religare is confident of the company clocking EBITDA margins of around 20.7 percent for FY16 and a similar number for FY17 too. Money Control, 2 months ago

FDC ban not done in proper manner; large brands to suffer: Pros

The government over the weekend banned 344 Fixed Dose Combinations (FDCs) drugs, which will impact nearly 4-5 percent of the Indian pharmaceutical industry. Kewal Handa, industry expert and former MD of Pfizer says that alongwith sales loss, ...
 Moneycontrol.com1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less